| Model Number |
FX804T |
| Medical Device Problem Code |
Insufficient Device Problem Information (3190)
|
| Health Effect - Clinical Code |
Hydrocephalus (3272)
|
| Date of Event |
03/18/2026
|
|
Type of Reportable Event
|
Serious Injury
|
|
Additional Manufacturer Narrative
|
|
Manufacturing site evaluation investigation on-going.Should relevant additional information or the investigation results become available, a supplemental medwatch report will be submitted.
|
| |
|
Event or Problem Description
|
|
It was reported that an m.Blue plus valve (#fx804t) was implanted during a procedure performed on an unspecified date.According to the complainant, the shunt system was not working properly.The patient underwent a revision procedure on (b)(6) 2026.No patient complications were reported as a result of the revision procedure.The complained device was not yet returned to the manufacturer for evaluation.Same event as medwatchno.: 3004721439-2026-00095.
|
| |
|
Additional Manufacturer Narrative
|
|
Visual inspection.During the investigation, scratches on the outer housing of the m.Blue, were determined.Permeability test.A permeability test has shown that both valves are permeable.Computer controlled test.To determine the opening pressure, the valve is measured using a computer-controlled testing device from miethke that simulates the flow of cerebrospinal fluid.The valves are tested in both horizontal and vertical positions.The results show that the valves are operating within the specified tolerances in their respective relevant position.Adjustment test.The valves were tested and wählen sie ein element aus.Braking force and brake function test.The brake functionality test has shown that the brake function operates as expected and the braking force is within the given tolerance.Internal inspection.After dismantling of the valves, organic deposits were found in the progav 2.0.Results.Based on our investigation results, we can determine visible deposits in both valves.The deposits had no effect upon the specifications at the time of the examination.The valves operated within all specifications.Organic material in the csf can temporarily influence the function and are known side effects in hydrocephalus therapy.The examination of the return has been completed with the drafting of this report.We can exclude a defect at the time of release.The shunt system met all specifications of the final inspection when released from (b)(6).
|
| |
|
Search Alerts/Recalls
|